|
Market Closed -
NSE India S.E.
16:22:05 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 632.60 INR | -3.46% |
|
+3.44% | +11.97% |
| Market Cap | 30.52B 321M 288M 265M 240M 449M 457M 3.16B 1.27B 16.06B 1.21B 1.18B 50.63B | P/E 2025 |
3,792x | P/E 2026 | -253x |
|---|---|---|---|---|---|
| Enterprise Value | 37.31B 393M 352M 324M 293M 548M 559M 3.86B 1.55B 19.63B 1.47B 1.44B 61.9B | EV / Sales 2025 |
2.54x | EV / Sales 2026 | 1.99x |
| Free-Float |
47.77% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SOLARA | Delayed | |
Bombay S.E.
| SOLARA | Delayed |
Last Transcript: Solara Active Pharma Sciences Limited
| 1 day | -3.46% | ||
| 1 week | +3.44% | ||
| 1 month | -12.79% | ||
| 3 months | +23.18% | ||
| 6 months | +27.59% | ||
| Current year | +11.97% |
| 1 week | 604.95 |  | 669 |
| 1 month | 525.15 | | 759 |
| Current year | 422 | | 774 |
| 1 year | 422 | | 774 |
| 3 years | 297.2 | | 882.8 |
| 5 years | 286 | | 1,384 |
| 10 years | 134.5 | | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Rao
CEO | Chief Executive Officer | - | 21/02/2025 |
Sarat Kumar
DFI | Director of Finance/CFO | - | 21/02/2025 |
Ajit Manocha
CTO | Chief Tech/Sci/R&D Officer | 74 | 10/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 11/04/2018 | |
| Director/Board Member | 58 | 11/04/2018 | |
| Director/Board Member | 75 | 14/11/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/03/25 | Buy | Director | 1,000 | 0.0021% | ||
| 06/03/25 | Pronomz Ventures LLP
| Buy | Company | 13,600 | 0.0283% | |
| 04/03/25 | Pronomz Ventures LLP
| Buy | Company | 216,361 | 0.4503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.46% | +3.44% | +5.47% | +107.10% | 321M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.53% | +5.65% | +42.47% | +86.82% | 426.23B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 12.84B 135M 121M 111M 101M 189M 192M 1.33B 533M 6.75B 507M 497M 21.3B | 13.69B 144M 129M 119M 108M 201M 205M 1.42B 569M 7.2B 541M 530M 22.71B |
| Net income | 5.4M 56.87K 50.93K 46.85K 42.45K 79.35K 80.84K 559K 224K 2.84M 213K 209K 8.96M | -74.1M -780K -699K -643K -583K -1.09M -1.11M -7.67M -3.08M -38.98M -2.93M -2.87M -123M |
| Net Debt | 7.92B 83.43M 74.72M 68.73M 62.27M 116M 119M 820M 329M 4.17B 313M 306M 13.14B | 6.79B 71.52M 64.05M 58.92M 53.38M 99.79M 102M 703M 282M 3.57B 268M 263M 11.27B |
Employees
1,669
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₹632.60 | -3.46% | 145,352 |
| 29/10/26 | ₹655.25 | +0.22% | 108,382 |
| 28/10/26 | ₹653.80 | +2.69% | 218,304 |
| 27/10/26 | ₹636.70 | +0.34% | 314,775 |
| 26/10/26 | ₹634.55 | +3.76% | 242,609 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions
